研究非自发四肢运动作为非基性高血糖症的表现特征
Srikant K Dhar1, Asif D Jafri2, Kaneez Fatima3
1Department of Medicine, Institute of Medical Sciences (IMS) and SUM Hospital, Bhubaneshwar, IND.
Cureus
|September 18, 2023
概括
过高血糖会导致肢体异常运动,如血糖和血球运动. 及时诊断和血糖控制可以有效地治疗高血糖患者的这些运动障碍.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 运动障碍 运动障碍
背景情况:
- 过高血糖症很少表现为 Hemichorea/hemiballismus. 这种情况很少发生.
- 这些非自愿的运动通常会随着血糖正常化而消失.
- 确定高血糖是原因对于可治愈的治疗至关重要.
研究的目的:
- 为了调查出现异常四肢运动和高血糖症的患者.
- 排除这些运动障碍的其他潜在原因.
- 为了突出高血糖引起的慢性病的可治疗性质.
主要方法:
- 在IMS和SUM医院进行了一年的观察研究 (2019年3月至2020年2月).
- 包括11个肢体运动异常和血糖≥250毫克%的病例.
- 排除了其他可识别的症状原因的患者.
主要成果:
- 这项研究包括11名患者 (7名男性,4名女性),平均年龄为66.5岁.
- 介绍的内容包括脑膜炎 (36.3%),脑膜炎 (18.1%),脑膜炎 (18.1%),脑膜炎 (9.1%) 和混合型 (18.1%).
- 纠正高血糖的平均时间为34小时;异常运动平均在90.54小时内消失. 81.8%的人在成像上显示基底腺节变化.
结论:
- 高血糖是 Hemichorea / hemiballismus 的一个重要的,可治疗的原因.
- 迅速识别和管理高血糖是解决这些神经症状的关键.
- 在这些患者的成像中,基底腺节的变化是常见的.
更多相关视频
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
15.0K
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
1.5K
相关概念视频
Restless Leg Syndrome and Night Terrors
203
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
203
Hypoglycemia and Glucagon
294
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
294
